Viking Therapeutics (VKTX) VANQUISH-1 Trial Completes Early, H.C. Wainwright Retains Buy Rating
Viking Therapeutics (VKTX) VANQUISH-1 Trial Completes Early, H.C. Wainwright Retains Buy Rating Sheryar Siddiq Sun, November 30, 2025 at 2:08 AM GMT+8 1 min read In this article: VKTX +1.49% Viking Th...